Medicare Enrolled
Dr. Mohan Deochand, MD
Neurology · Sanford, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Deochand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deochand?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Deochand
Dr. Mohan Deochand is a neurology specialist in Sanford, NC, with 19 years of NPI registration. Based on federal Medicare data, Dr. Deochand performed 1,340 Medicare services across 735 unique beneficiaries.
Between the years covered by Open Payments, Dr. Deochand received a total of $10,518 from 67 pharmaceutical and/or device companies across 820 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Deochand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in NC
$10,518 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,340
Medicare services
Top 15% in NC for neurology
735
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
622 | $58 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
314 | $62 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
132 | $100 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $84 | $205 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $121 | $275 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
39 | $69 | $290 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
19 | $252 | $600 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
19 | $81 | $700 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
15 | $64 | $500 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
11 | $85 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,518
Total received (2018-2024)
Avg $1,503/year across 7 years
Top 21% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
820
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,177 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$341 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,708
2023
$1,232
2022
$2,181
2021
$2,107
2020
$1,585
2019
$990
2018
$715
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ANI Pharmaceuticals, Inc.
$201
Neurelis, Inc.
$176
PFIZER INC.
$153
Novartis Pharmaceuticals Corporation
$151
JAZZ PHARMACEUTICALS INC.
$149
Mallinckrodt Hospital Products Inc.
$84
Lundbeck LLC
$81
ABBVIE INC.
$74
Teva Pharmaceuticals USA, Inc.
$69
Otsuka America Pharmaceutical, Inc.
$63
Eisai Inc.
$54
UCB, Inc.
$50
TG Therapeutics, Inc.
$49
Takeda Pharmaceuticals U.S.A., Inc.
$39
HARMONY BIOSCIENCES LLC
$38
Biogen, Inc.
$37
Kedrion Biopharma, Inc.
$36
Lilly USA, LLC
$36
Sumitomo Pharma America, Inc.
$32
Harmony Biosciences Llc
$31
Axsome Therapeutics, Inc.
$29
Alexion Pharmaceuticals, Inc.
$20
Terumo Medical Corporation
$18
Amgen Inc.
$17
Genentech USA, Inc.
$15
Aucta Pharmaceuticals, Inc.
$7
Top 3 companies account for 31.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$765
Supernus Pharmaceuticals, Inc.
$741
JAZZ PHARMACEUTICALS INC.
$653
Adamas Pharmaceuticals, Inc.
$547
Biogen, Inc.
$534
Mallinckrodt Hospital Products Inc.
$502
Harmony Biosciences LLC
$385
Amgen Inc.
$358
Lilly USA, LLC
$339
Alexion Pharmaceuticals, Inc.
$325
Neurelis, Inc.
$321
Teva Pharmaceuticals USA, Inc.
$283
SK Life Science, Inc.
$281
PFIZER INC.
$270
UCB, Inc.
$258
Lundbeck LLC
$253
AbbVie Inc.
$253
Greenwich Biosciences, Inc.
$243
ANI Pharmaceuticals, Inc.
$214
ABBVIE INC.
$210
Avanir Pharmaceuticals, Inc.
$201
Biohaven Pharmaceutical Holding Company Ltd.
$187
Eisai Inc.
$179
Amneal Pharmaceuticals LLC
$164
EISAI INC.
$135
Jazz Pharmaceuticals Inc.
$132
Biohaven Pharmaceuticals, Inc.
$128
HARMONY BIOSCIENCES LLC
$126
Acorda Therapeutics, Inc
$117
Otsuka America Pharmaceutical, Inc.
$94
Axsome Therapeutics, Inc.
$79
EMD Serono, Inc.
$73
Avion Pharmaceuticals
$69
Sunovion Pharmaceuticals Inc.
$66
Merck Sharp & Dohme Corporation
$64
Impax Laboratories, Inc.
$56
Corium, LLC
$52
Janssen Pharmaceuticals, Inc
$52
TG Therapeutics, Inc.
$49
IDORSIA PHARMACEUTICALS US INC
$42
CSL Behring
$41
AstraZeneca Pharmaceuticals LP
$41
MDD US Operations, LLC
$40
Takeda Pharmaceuticals U.S.A., Inc.
$39
Mallinckrodt LLC
$39
Exeltis, USA Inc.
$38
Aprecia Pharmaceuticals, LLC
$37
Kedrion Biopharma, Inc.
$36
Kyowa Kirin, Inc.
$33
Sumitomo Pharma America, Inc.
$32
Harmony Biosciences Llc
$31
Mallinckrodt Enterprises LLC
$30
IMPEL PHARMACEUTICALS INC.
$29
GENZYME CORPORATION
$28
UPSHER-SMITH LABORATORIES LLC
$25
Upsher-Smith Laboratories LLC
$25
LivaNova USA, Inc.
$24
AbbVie, Inc.
$20
Terumo Medical Corporation
$18
Strongbridge US INC.
$17
Bausch Health US, LLC
$17
Alnylam Pharmaceuticals Inc.
$16
Genentech USA, Inc.
$15
Grifols USA, LLC
$13
AngioDynamics, Inc.
$13
Mitsubishi Tanabe Pharma America, Inc.
$13
Aucta Pharmaceuticals, Inc.
$7
Top 3 companies account for 20.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · ALPHAVAC · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AZUR CX DETACHABLE · Adlarity · Aimovig · Albuked · Austedo XR · BELSOMRA · BRILINTA · BRIUMVI · Briviact · COMIRNATY · DUOPA · Dayvigo · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · INBRIJA · KESIMPTA · KEVEYIS · LEMTRADA · LEQEMBI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Motpoly XR · NORTHERA · NUEDEXTA · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · ONPATTRO · OXTELLAR XR · Ocrevus · PANZYGA · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYTARY · Radicava · Rebif · SKYCLARYS · SOLIRIS · SPINRAZA · SUNOSI · Soliris · Spritam · Sunosi · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · Vimpat · WAKIX · Wakix · XYREM · XYWAV
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
8
Per 100K population
12.4
County median income
$63,060
Nearest hospital
CENTRAL CAROLINA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Deochand is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NC), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Deochand experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Deochand performed 622 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deochand receive payments from pharmaceutical companies?
Yes. Dr. Deochand received a total of $10,518 from 67 companies across 820 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deochand's costs compare to other neurologists in Sanford?
Dr. Deochand's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deochand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Sanford
Browse neurologists in Sanford ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
JAZZ PHARMACEUTICALS INC. Payments to Doctors
See all physicians who received payments from JAZZ PHARMACEUTICALS INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology